Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Therma Bright Inc (TSV: THRM )

0.0600 UNCHANGED
Streaming Delayed Price Updated: 3:05 PM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0600
Bid (Size) 0.0550 (3,390)
Ask (Size) 0.0600 (440)
Prev. Close 0.0600
Today's Range 0.0600 - 0.0600
52wk Range 0.0500 - 0.2200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Therma Bright Expands U.S. Distribution of Venowave Device to Increase Sales Under Temporary CPT(R) & HCPCS Codes
Toronto, Ontario--(Newsfile Corp. - May 25, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Therma Bright Initiates Data Collection with AI Digital Cough Technology App at TB Clinics
Toronto, Ontario--(Newsfile Corp. - May 10, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Artificial Intelligence Death
Exposures Artificial Intelligence COVID-19 Death

Performance

YTD
N/A
N/A
1 Month
-7.69%
-7.69%
3 Month
-40.00%
-40.00%
6 Month
-25.00%
-25.00%
1 Year
-61.29%
-61.29%

More News

Read More
Therma Bright Milestone Payments Bring Ownership in Inretio to 7.5%
Via Newsfile
Therma Bright Secures Medicare and Medicaid Reimbursement for Venowave Device
Via Newsfile
Therma Bright Prepares Launch of Digital Cough Screening and Data Collection Smartphone Application
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
Therma Bright's Investment Partner Inretio Moves to New Manufacturing Facility
Via Newsfile
Exposures Product Safety
Therma Bright Reports on Progress of Inretio's Novel Clot Removal Device for Stroke Treatment
Via Newsfile
Therma Bright Secures Exclusive License Agreement for AI4LYF's Patent-Pending Digital Cough Technology (DCT) to Detect Respiratory Diseases
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Therma Bright Inc. Invests in Ischemic Stroke Blood Clot Retriever Technology Company Inretio Inc. based in Israel
Via Newsfile
Exposures COVID-19
Therma Bright Provides 2022 Year End Update
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Invests in the Development of Novel Treatments for COVID-19, Asthma, and Chronic Obstructive Pulmonary Disease (COPD)
Via Newsfile
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Therma Bright Inc. to Acquire an Exclusive License for a Patented Digital Cough Based Technology to Detect Respiratory Diseases
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19 Product Safety
Therma Bright Receives New Billing Codes for Venowave Allowing for Reimbursement from Medicare, Medicaid, and Private Insurers
Via Newsfile
Exposures COVID-19
Therma Bright Receives Payment for Initial Venowave Sales
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Supply Chain
Therma Bright Provides Update on FDA EUA Review Process
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Product Safety Supply Chain
Therma Bright Provides Progress Update on FDA EUA & Health Canada Interim Order Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care (POC)
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Provides Update on FDA EUA Application Process For AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright to Submit Application to Health Canada for Approval of its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Product Safety Supply Chain
Therma Bright Ships Initial Venowave Order to US Distributor
Via Newsfile
Exposures COVID-19
Therma Bright Submits AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Application for U.S. Food & Drug Administration's Emergency Use Authorization (EUA)
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Receives Patent for a Device for Applying a Topical Treatment from U.S. Patent & Trademark Office (USPTO)
Via Newsfile
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Therma Bright's AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration's Emergency Use Authorization Requirements
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Completes U.S. Clinical Performance Study Subject Recruitment
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Provides Update on U.S. Clinical Performance Study
Via Newsfile
Exposures COVID-19 Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.